NKTR — Nektar Therapeutics Share News
0.000.00%
Last trade - 00:00- $1.32bn
- $692.66m
- $55.23m
U.S. RESEARCH ROUNDUP-Factset, Metlife, Replimune Group
Brief: Nektar Says REZOLVE-AD Phase 2B Results For Rezpegaldesleukin Selected For Oral Presentation At EADV 2025
Nektar Therapeutics reports results for the quarter ended June 30 - Earnings Summary
Nektar Therapeutics Q2 revenue drops 52%
Nektar Therapeutics expected to post a loss of $3.03 a share - Earnings Preview
Brief: Nektar Therapeutics Receives Fast Track Designation For Rezpegaldesleukin For The Treatment Of Severe-To-Very Severe Alopecia Areata
U.S. RESEARCH ROUNDUP-Hershey, Metlife, Voya Financial
U.S. STOCKS ON THE MOVE-Energy stocks, Apple, Vertex
U.S. STOCKS ON THE MOVE-Snap, Solventum, GlobalFoundries
U.S. STOCKS ON THE MOVE-NIP Group, Hyatt, BioXcel Therapeutics
Nektar Therapeutics edges lower after $100 mln stock sale
Brief: Nektar Therapeutics Announces Pricing Of $100 Million Public Offering
Nektar Therapeutics dips after announcing equity offering
Brief: Nektar Therapeutics Announces Proposed Public Offering
Advisory: Research alert on Nektar Therapeutics refiled to clarify price target
U.S. RESEARCH ROUNDUP- Fedex, Omnicom Group, Texas Instruments
U.S. STOCKS ON THE MOVE-FedEx, Galaxy Digital, Cheniere Energy
U.S. STOCKS ON THE MOVE-Union Pacific, Micron, Uber
U.S. STOCKS ON THE MOVE-US airlines, Snowflake, Supermicro